|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4704 | |
| A61K 39/395 | |||
| A61K 39/00 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| C07K 16/28 |
| (11) | Patento numeris | 3268031 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16705122.6 |
| Europos patento paraiškos padavimo data | 2016-02-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/053288 |
| Data | 2016-02-16 |
| (87) | Numeris | WO 2016/146329 |
| Data | 2016-09-22 |
| (30) | Numeris | Data | Šalis |
| 15290069 | 2015-03-13 | EP |
| (72) |
SOARES, José Amauri, FR
CHETAILLE, Eric, FR
NAKHLE, Jessica, FR
SCHMIDLIN, Fabien, FR
|
| (73) |
Active Biotech AB,
Scheelevägen 22, 223 63 Lund,
SE
|
| (54) | COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT |
| COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT |